Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute for Molecular Infection Biology (IMIB) in Würzburg want to better understand how the oral cavity germ Fusobacterium...
The Federal Agency for Disruptive Innovation (SPRIND) is pleased to announce the participants of the second phase of the SPRIND Challenge "A Quantum Shift for New Antiviral Agents". Six teams will each receive up to 1.5...
Martin Korte researches the influence of infections and infection-associated inflammations on neurodegenerative diseases that damage, for example, learning processes or memory. Korte is group leader of the...
Many people suffer from neurodermatitis (atopic dermatitis) or psoriasis. These chronic inflammatory diseases, which have so far been incurable, can lead to a significant loss of quality of life due to the agonising...
Dr Peggy Riese is a scientist in the Department of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany. Her research focuses on the special features of the...
In their search for new substances that are effective against infectious diseases, researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are extracting natural substances from soil bacteria....
Founded in April 2022, the Helmholtz Institute for One Health (HIOH) in Greifswald is a new branch of the HZI. What exactly does One Health mean? And why is this research approach particularly important today?
...
Christian Sieben decided in favour of biology thanks to his older sister, also a biologist, who gave him an early glimpse behind the scenes of this field of study. But the 40-year old‘s career path was anything but...
The transfer of research results into application is an important goal of the scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. The GO-Bio initial programme of the German Federal Ministry...
